Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine vs Fentanyl vs Midazolam for Pediatric Laceration Repair
NCT05057689Phase 2Withdrawn
- Sponsor
- Nationwide Children's Hospital
- Start
- Sep 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in pain, anxiety disorder, sponsored by Nationwide Children's Hospital. Planned start Sep 2025; status: withdrawn.
02
Drugs
dexmedetomidine
03
Conditions
painanxiety disorder
Beyond the preview
Go deeper on NCT05057689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05057689.